- Master's Degrees
- Actuarial Science Online
- Bioethics Online
- Critical Issues in International Relations
- Ecology, Evolution, and Environmental Biology
- Graduate Foundations
- Human Rights
- Quantitative Studies for Finance
- Sustainability Analytics
- Sustainable Water Management
- United Nations Studies
- Graduate Preparation
- Take Courses
- Business Offerings
- Summer Study
- Columbia Summer Overview
- High School Summer Programs Overview
- High School Programs
- American Language Programs
- Programs Overview
- Intensive English Program
- Part-Time English Programs
- Special Programs
- Executive Programs and Seminars
- Auditing Programs
- Coming Soon
Stopping the spread of Ebola entails a new dilemma -- challenging long-standing rituals of an at-risk community, writes Bioethics director Robert Klitzman in The Huffington Post.
Alex Fischer, Senior Advisor for the Environment, Peace, and Security Executive Seminar, talks about the nonprofit work that inspired him to explore the link between climate and conflict.
Negotiation and Conflict Resolution professor Peter T. Coleman critiques Putin's domineering leadership style and suggests alternative approaches to conflict resolution.
On Monday, the School of Continuing Education welcomed its largest ever incoming class of graduate students. These students will pursue M.S. degrees in thirteen different master's programs.
Vince Gennaro, director of Sports Management and president of Society for American Baseball Research (SABR), highlights the growth of stats in baseball and discusses future applications for such metrics.
Where does spirituality fit into medical practice? To find out, Medscape spoke with Bioethics program director Robert Klitzman.
The rising senior gains a competitive edge during the summer with one-on-one mentorship, an engaging internship, and a graduate-level class at Columbia.
From an ethical perspective, can clinicians treat the fast-spreading Ebola virus with experimental drugs? Bioethics director Robert Klitzman weighs in.
Who gets access to an experimental, new treatment for the fast-spreading Ebola virus? Robert Klitzman weighs in.
On ABC News, Robert Klitzman comments on questions surrounding ZMapp, the new Ebola treatment whose limited supply raises questions about who should receive treatment first.